AtriCure (ATRC) Capital Expenditures Growth (3y) (2013 - 2026)
AtriCure (ATRC) Capital Expenditures Growth (3y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | -29.93% |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | -11.61% |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | -10.15% |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | - |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | 5.31% |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | -16.94% |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | 8.92% |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | 5.49% |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | -21.70% |
| 10 | AtriCure | 1.80 Bn | 1.65 Bn | 109.31 Mn | 69.79% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 69.79% |
| Dec 31, 2025 | 43.80% |
| Sep 30, 2025 | 129.95% |
| Jun 30, 2025 | -48.59% |
| Mar 31, 2025 | 11.87% |
| Dec 31, 2024 | 35.55% |
| Sep 30, 2024 | 33.87% |
| Jun 30, 2024 | -17.29% |
| Mar 31, 2024 | 27.90% |
| Dec 31, 2023 | 50.30% |
| Sep 30, 2023 | 51.20% |
| Jun 30, 2023 | -38.47% |
| Mar 31, 2023 | -24.55% |
| Dec 31, 2022 | -13.10% |
| Sep 30, 2022 | 34.22% |
| Jun 30, 2022 | -28.50% |
| Mar 31, 2022 | -3.04% |
| Dec 31, 2021 | -4.73% |
| Sep 30, 2021 | -3.14% |
| Jun 30, 2021 | 44.82% |